U.S. flag

An official website of the United States government

NM_000282.4(PCCA):c.1138dup (p.Tyr380fs) AND Propionic acidemia

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 8, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003841300.2

Allele description [Variation Report for NM_000282.4(PCCA):c.1138dup (p.Tyr380fs)]

NM_000282.4(PCCA):c.1138dup (p.Tyr380fs)

Gene:
PCCA:propionyl-CoA carboxylase subunit alpha [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
13q32.3
Genomic location:
Preferred name:
NM_000282.4(PCCA):c.1138dup (p.Tyr380fs)
HGVS:
  • NC_000013.11:g.100301532dup
  • NG_008768.1:g.217450dup
  • NM_000282.4:c.1138dupMANE SELECT
  • NM_001127692.3:c.1060dup
  • NM_001178004.2:c.1138dup
  • NM_001352605.2:c.1138dup
  • NM_001352606.2:c.1066-1392dup
  • NM_001352607.2:c.1060dup
  • NM_001352608.2:c.988-1392dup
  • NM_001352609.2:c.1138dup
  • NM_001352610.2:c.193dup
  • NM_001352611.2:c.193dup
  • NM_001352612.2:c.121-1392dup
  • NP_000273.2:p.Tyr380fs
  • NP_001121164.1:p.Tyr354fs
  • NP_001171475.1:p.Tyr380fs
  • NP_001339534.1:p.Tyr380fs
  • NP_001339536.1:p.Tyr354fs
  • NP_001339538.1:p.Tyr380fs
  • NP_001339539.1:p.Tyr65fs
  • NP_001339540.1:p.Tyr65fs
  • NC_000013.10:g.100953785_100953786insT
  • NC_000013.10:g.100953786dup
  • NR_148027.2:n.1166dup
  • NR_148028.2:n.1166dup
  • NR_148029.2:n.1088dup
  • NR_148030.2:n.1166dup
  • NR_148031.2:n.1166dup
Protein change:
Y354fs
Molecular consequence:
  • NM_000282.4:c.1138dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001127692.3:c.1060dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001178004.2:c.1138dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001352605.2:c.1138dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001352607.2:c.1060dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001352609.2:c.1138dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001352610.2:c.193dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001352611.2:c.193dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001352606.2:c.1066-1392dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001352608.2:c.988-1392dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001352612.2:c.121-1392dup - intron variant - [Sequence Ontology: SO:0001627]
  • NR_148027.2:n.1166dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148028.2:n.1166dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148029.2:n.1088dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148030.2:n.1166dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148031.2:n.1166dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Propionic acidemia (PROP)
Synonyms:
Glycinemia, ketotic; Hyperglycinemia with ketoacidosis and leukopenia; Ketotic hyperglycinemia
Identifiers:
MONDO: MONDO:0011628; MedGen: C0268579; Orphanet: 35; OMIM: 606054; Human Phenotype Ontology: HP:0003571

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004694750Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 8, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Propionic acidemia: mutation update and functional and structural effects of the variant alleles.

Desviat LR, Pérez B, Pérez-Cerdá C, Rodríguez-Pombo P, Clavero S, Ugarte M.

Mol Genet Metab. 2004 Sep-Oct;83(1-2):28-37. Review.

PubMed [citation]
PMID:
15464417

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004694750.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This sequence change creates a premature translational stop signal (p.Tyr380Leufs*9) in the PCCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PCCA are known to be pathogenic (PMID: 15464417). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PCCA-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024